Modified Solanaceous Defensins for Pathogen Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for controlling plant pathogens, such as fungal pathogens, rely heavily on chemical pesticides, which pose environmental and regulatory concerns and contribute to resistance development, necessitating alternative mechanisms for inducing resistance in plants.

Innovation Solution

Development of artificially modified Class II solanaceous defensins with enhanced anti-pathogen activity by modifying the loop region between the first β-strand and the α-helix, specifically the Loop 1B region, to improve stability and membrane permeabilization capacity, allowing for broader spectrum and increased effectiveness against pathogens.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemical pesticides are used to control plant pathogens, then pathogen control effectiveness is improved, but environmental harm and resistance development increase

Engineering Contradiction:
Improvepathogen control effectivenessVSAvoidenvironmental harm and resistance development
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the amino acid sequence of defensin proteins by changing specific parameters (amino acid composition, disulfide bond configuration) to enhance their anti-pathogen activity. This creates more effective biological control agents that can reduce pathogen pressure without the harmful effects of chemical pesticides.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite defensive systems by combining modified defensin proteins with other plant defense mechanisms. The engineered defensins work synergistically with plant immune responses to provide robust pathogen control while avoiding the drawbacks of standalone chemical pesticide application.

Inventive Principle:
Principle #40Composite materials

2Reliability

If defensin loop region is modified to enhance anti-pathogen activity, then membrane permeabilization capacity is improved, but protein stability may be compromised

Engineering Contradiction:
Improvemembrane permeabilization capacityVSAvoidprotein stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies local quality changes by modifying only specific regions of the defensin protein (particularly the loop regions) while maintaining the overall structural framework. This localized modification enhances membrane permeabilization capacity without destabilizing the entire protein structure, as the core disulfide-bonded framework remains intact.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent carefully adjusts parameters within the loop regions (amino acid substitutions, additions, or deletions) to optimize membrane interaction while monitoring and maintaining overall protein stability. The modifications are designed to achieve the desired functional enhancement without compromising structural integrity.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS10174339B2Modified plant defensins useful as anti-pathogenic agents
Publication Date: 2019.01.08 HEXIMA LTD
  • US10174339B2 patent drawing
  • US10174339B2 patent drawing
  • US10174339B2 patent drawing

AI summary

This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.